EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors

EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors

Li D, Guo X, Yang K, Yang Y, Zhou W, Huang Y, Liang X, Su J, Jiang L, Li J, Fu M, He H, Yang J, Shi H, Yang H, Tong A, Chen N, Hu J, Xu Q, Wei YQ, Wang W. EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors. Sci Adv. 2023 Dec;9(48):eadg9721.

Used in this study:B-hEPCAM mice, B-NDG mice

Read entire article

Share:

Back to top